DIANTHUS THERAPEUTICS

18.43

23-May-25 13:45:00

15 minutes delayed

Stocks

+0.07

+0.35%

Today's range

17.72 - 18.83

ISIN

N/A

Source

NASDAQ

Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting

11 Apr 2024 04:30:00 By Nasdaq GlobeNewswire
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Apr 2024 13:30:00 By Nasdaq GlobeNewswire
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results

21 Mar 2024 13:01:00 By Nasdaq GlobeNewswire
Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

07 Mar 2024 13:30:00 By Nasdaq GlobeNewswire
Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)

26 Feb 2024 04:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.